Arrowstreet Capital, Limited Partnership »

Perspective Therapeutics shares owned by Arrowstreet Capital, Limited Partnership

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Arrowstreet Capital, Limited Partnership from 13F filings

Historical chart of Arrowstreet Capital, Limited Partnership investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Arrowstreet Capital, Limited Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Arrowstreet Capital, Limited Partnership

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 102k 13.35

More positions owned by Arrowstreet Capital, Limited Partnership

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Meta Platforms Cl A (META)
At&t (T)
Eli Lilly & Co. (LLY)
Wells Fargo & Company (WFC)
JPMorgan Chase & Co. (JPM)
General Motors Company (GM)
Bank of America Corporation (BAC)
Comcast Corp Cl A (CMCSA)
Altria (MO)
MercadoLibre (MELI)
Hca Holdings (HCA)
Netflix (NFLX)

View all positions for Arrowstreet Capital, Limited Partnership

Top funds holding Perspective Therapeutics

Henderson Group
BlackRock
BlackRock
Avidity Partners Management
Commodore Capital
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Marshall Wace
Octagon Capital Advisors
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors

View all funds holding Perspective Therapeutics